tiprankstipranks
Brainstorm Cell Therapeutics (BCLI)
OTHER OTC:BCLI
US Market
BCLI
Brainstorm Cell Therapeutics
RESEARCH TOOLSreports
Want to see BCLI full AI Analyst Report?

Brainstorm Cell Therapeutics (BCLI) Financial Statements

572 Followers

Brainstorm Cell Therapeutics Financial Overview

Brainstorm Cell Therapeutics's market cap is currently $7.95M. The company's EPS TTM is $-0.94; its P/E ratio is -1.23; Brainstorm Cell Therapeutics is scheduled to report earnings on May 15, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -240.00K$ -265.00K$ -285.00K$ -260.00K
Operating Income$ -9.95M$ -11.69M$ -21.44M$ -24.82M$ -24.54M
EBITDA$ -9.75M$ -11.31M$ -16.93M$ -23.99M$ -24.28M
Net Income$ -10.31M$ 11.62M$ -17.19M$ -24.28M$ -24.46M
Balance Sheet
Cash & Short-Term Investments$ 29.00K$ 187.00K$ 1.30M$ 2.98M$ 22.09M
Total Assets$ 715.00K$ 1.83M$ 4.21M$ 8.45M$ 29.28M
Total Debt$ 208.00K$ 720.00K$ 1.27M$ 4.09M$ 5.08M
Net Debt$ 179.00K$ 533.00K$ -25.00K$ 3.32M$ -13.78M
Total Liabilities$ 11.01M$ 9.60M$ 9.07M$ 11.47M$ 9.94M
Stockholders' Equity$ -10.29M$ -7.76M$ -4.86M$ -3.02M$ 19.34M
Cash Flow
Free Cash Flow$ -6.97M$ -9.09M$ -20.48M$ -19.35M$ -26.59M
Operating Cash Flow$ -6.97M$ -9.09M$ -20.46M$ -19.32M$ -26.27M
Investing Cash Flow$ 0.00$ 12.00K$ 2.19M$ 998.00K$ 323.00K
Financing Cash Flow$ 6.88M$ 7.97M$ 18.98M$ 238.00K$ 6.97M
Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History

Income Statement >

Brainstorm Cell Therapeutics Debt to Assets

Balance Sheet >

Brainstorm Cell Therapeutics Cash Flow

Cash Flow >

Brainstorm Cell Therapeutics Forecast EPS vs Actual EPS

Earnings >